Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Asset Writedowns and Impairment (2023 - 2025)

Puma Biotechnology's Asset Writedowns and Impairment history spans 3 years, with the latest figure at $400000.0 for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 195.47% year-over-year to $400000.0; the TTM value through Dec 2025 reached $213000.0, up 134.41%, while the annual FY2024 figure was -$519000.0, 157.67% down from the prior year.
  • Asset Writedowns and Impairment reached $400000.0 in Q4 2025 per PBYI's latest filing, up from -$100000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $514000.0 in Q2 2023 to a low of -$419000.0 in Q4 2024.
  • Average Asset Writedowns and Impairment over 3 years is $44909.1, with a median of $100000.0 recorded in 2024.
  • Peak YoY movement for Asset Writedowns and Impairment: crashed 252.36% in 2024, then surged 195.47% in 2025.
  • A 3-year view of Asset Writedowns and Impairment shows it stood at $275000.0 in 2023, then plummeted by 252.36% to -$419000.0 in 2024, then surged by 195.47% to $400000.0 in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Asset Writedowns and Impairment are $400000.0 (Q4 2025), -$100000.0 (Q3 2025), and -$300000.0 (Q2 2025).